compound glp 1 Compounded" GLP-1 drugs | Health Communication Research Laboratory If it's not FDA-approved, it's

Here is the most important takeaway: As of late 2025, there are no FDA-approved GLP-1 medication patches (semaglutide, tirzepatide, or others) commercially available from a legitimate pharmacy

This is a safe, non-invasive first step for anyone curious about their current health status or looking for a clear baseline before starting any lifestyle or medical intervention

However, the small study population, open-label design and the lack of blindness are significant limitations that need to be considered when interpreting the data

Kiesewetter DO, Guo N, Guo J, Gao H, Zhu L, Ma Y, Niu G, Chen X

Dellgren JL, Persad G, Emanuel EJ

Type II agents target both GLP-1R and gastric inhibitory polypeptide receptor (GIPR), exemplified by tirzepatide, which, as the first dual-receptor agonist, demonstrates significant advantages in weight reduction and metabolic regulation